A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease

Trial Identifier: D6580C00004
Sponsor: AstraZeneca
NCTID:: NCT03136991
Start Date: May 2017
Primary Completion Date: November 2017
Study Completion Date: November 2017
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, CA Glendale, CA, United States of America, 91206